methylprednisolone has been researched along with Cerebrovascular Moyamoya Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, Z; Gokhale, S; Zhou, G | 1 |
Ahn, HJ; Choi, SJ; Chung, IS; Gwak, MS; Kim, HS; Kim, JA; Kim, JK; Lee, JJ; Shin, HJ | 1 |
Johnson, LH; Tenney, J | 1 |
Mok, CC; Poon, WL | 1 |
1 trial(s) available for methylprednisolone and Cerebrovascular Moyamoya Disease
Article | Year |
---|---|
Effect of preoperative skull block on pediatric moyamoya disease.
Topics: Adolescent; Anesthetics, Inhalation; Bupivacaine; Carbon Dioxide; Cerebrovascular Circulation; Child; Child, Preschool; Delirium; Female; Hemodynamics; Humans; Male; Methyl Ethers; Methylprednisolone; Moyamoya Disease; Nerve Block; Pain, Postoperative; Postoperative Complications; Sevoflurane; Skull | 2008 |
3 other study(ies) available for methylprednisolone and Cerebrovascular Moyamoya Disease
Article | Year |
---|---|
Moyamoya syndrome as an unusual presenting manifestation of systemic lupus erythematosus in a young woman.
Topics: Adult; Cerebral Angiography; Female; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Middle Cerebral Artery; Moyamoya Disease | 2014 |
Moyamoya disease in an 8-year-old boy presenting with weakness.
Topics: Anti-Inflammatory Agents; Aspirin; Attention Deficit Disorder with Hyperactivity; Brain Ischemia; Child; Combined Modality Therapy; Diagnosis, Differential; Drug Therapy, Combination; Encephalitis; Headache; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Moyamoya Disease; Muscle Weakness; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Respiratory Tract Infections; Tomography, X-Ray Computed | 2009 |
Moyamoya phenomenon in systemic lupus erythematosus.
Topics: Anticoagulants; Carotid Artery, Internal; Cerebral Angiography; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Moyamoya Disease; Pulse Therapy, Drug; Tomography, X-Ray Computed; Treatment Outcome; Vasculitis; Young Adult | 2011 |